Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The use of progestogen in the treatment of metastatic carcinoma of the kidney and uterine body.

Literature DB >> 5451569

The use of progestogen in the treatment of metastatic carcinoma of the kidney and uterine body.

Abstract

The effect of the progestogen medroxyprogesterone acetate on metastases from renal, endometrial and other tumours has been studied in 25 patients. Seven patients with renal and endometrial tumours had a useful response, pulmonary metastases and a large primary renal tumour showing the greatest effect. Bony metastases were unaffected by the drug and were treated by local radiotherapy. If a response occurred, it did so within 3 months.

Entities: Chemical Disease Species

Mesh：

Substances：
Medroxyprogesterone

Year: 1970 PMID： 5451569 PMCID： PMC2008579 DOI： 10.1038/bjc.1970.31

Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640

6 in total

1. HORMONES AND THE KIDNEY: POSSIBLE THERAPEUTIC ROLE OF TESTOSTERONE IN A PATIENT WITH REGRESSION OF METASTASES FROM RENAL ADENOCARCINOMA.

Authors: H J BLOOM; D M WALLACE
Journal: Br Med J Date: 1964-08-22

2. Progestins in the treatment of patients with endometrial adenocarcinoma.

Authors: J P Smith; F Rutledge; S W Soffar
Journal: Am J Obstet Gynecol Date: 1966-04-01 Impact factor: 8.661

3. Androgens in metastatic renal adenocarcinoma.

Authors: R D Jenkin
Journal: Br Med J Date: 1967-02-11

4. Medroxyprogesterone acetate in the treatment of renal cell carcinoma (hypernephroma).

Authors: M L Samuels; P Sullivan; C D Howe
Journal: Cancer Date: 1968-09 Impact factor: 6.860

5. HORMONE-DEPENDENT TUMOURS OF THE KIDNEY. I. THE OESTROGEN-INDUCED RENAL TUMOUR OF THE SYRIAN HAMSTER. HORMONE TREATMENT AND POSSIBLE RELATIONSHIP TO CARCINOMA OF THE KIDNEY IN MAN.

Authors: H J BLOOM; C E DUKES; B C MITCHLEY
Journal: Br J Cancer Date: 1963-12 Impact factor: 7.640

6. The histogenesis of stilboestrol-induced renal tumours in the male golden hamster.

Authors: E S HORNING; J W WHITTICK
Journal: Br J Cancer Date: 1954-09 Impact factor: 7.640

6 in total

5 in total

5. Modulation of adriamycin resistance in human breast carcinoma MCF-7 cells in vitro and in vivo by medroxyprogesterone acetate.

Authors: H Ishida; M Okabe; K Gomi; R Horiuchi; K Mikami; M Naito; T Tsuruo
Journal: Jpn J Cancer Res Date: 1994-05

5 in total

The use of progestogen in the treatment of metastatic carcinoma of the kidney and uterine body.

1. HORMONES AND THE KIDNEY: POSSIBLE THERAPEUTIC ROLE OF TESTOSTERONE IN A PATIENT WITH REGRESSION OF METASTASES FROM RENAL ADENOCARCINOMA.

2. Progestins in the treatment of patients with endometrial adenocarcinoma.

3. Androgens in metastatic renal adenocarcinoma.

4. Medroxyprogesterone acetate in the treatment of renal cell carcinoma (hypernephroma).

5. HORMONE-DEPENDENT TUMOURS OF THE KIDNEY. I. THE OESTROGEN-INDUCED RENAL TUMOUR OF THE SYRIAN HAMSTER. HORMONE TREATMENT AND POSSIBLE RELATIONSHIP TO CARCINOMA OF THE KIDNEY IN MAN.

6. The histogenesis of stilboestrol-induced renal tumours in the male golden hamster.

1. Progestogens and cancer.

Review 2. Long acting contraceptives. Present status.

3. Medroxyprogesterone acetate (Provera) in the treatment of metastatic renal cancer.

4. Hormonal treatment of metastases of renal carcinoma.

5. Modulation of adriamycin resistance in human breast carcinoma MCF-7 cells in vitro and in vivo by medroxyprogesterone acetate.